Merck & Co., Inc. is a global health care company delivering innovative health solutions through prescription medicines, biologic therapies, vaccines, and animal health products. Key products include Keytruda (pembrolizumab) for oncology, Gardasil 9 for HPV prevention, Winrevair for pulmonary arterial hypertension, Januvia for type 2 diabetes, and a broad animal health portfolio covering livestock and companion animals.
expected 2026-09-17
| Name | Role | Period |
|---|---|---|
| Christopher | Analyst, Schott JPMorgan Chase & Co | ? – present |
| Steve | Analyst Michael Nedelcovych TD Cowen - Analyst, Scala TD Cowen | ? – present |
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | MRK | discussed Artificial Intelligence | |
| topic_mention | MRK | discussed Blockchain & Crypto | |
| topic_mention | MRK | discussed Regulation | |
| topic_mention | MRK | discussed Healthcare & Bio | |
| topic_mention | MRK | discussed Regulation | |
| topic_mention | MRK | discussed Healthcare & Bio | |
| topic_mention | MRK | discussed Cybersecurity | |
| topic_mention | MRK | discussed Blockchain & Crypto | |
| topic_mention | MRK | discussed Regulation | |
| topic_mention | MRK | discussed Healthcare & Bio | |
| topic_mention | MRK | discussed Regulation | |
| topic_mention | MRK | discussed Healthcare & Bio | |
| topic_mention | MRK | discussed Supply Chain | |
| topic_mention | MRK | discussed Regulation | |
| topic_mention | MRK | discussed Sovereign & Government | |
| topic_mention | MRK | discussed Automotive | |
| topic_mention | MRK | discussed Healthcare & Bio | |
| metric | MRK gross margin | reported $66.2 percent | |
| metric | MRK gross margin | reported $74.8 percent | |
| metric | MRK gross margin | reported $79.7 percent |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-24 | 2025-12-31 | 0000310158-26-000063 | EDGAR | 100K words |
| 2025-02-25 | 2024-12-31 | 0001628280-25-007732 | EDGAR | — |
| 2024-02-26 | 2023-12-31 | 0001628280-24-006850 | EDGAR | — |
| 2023-02-24 | 2022-12-31 | 0001628280-23-005061 | EDGAR | — |
| 2022-02-25 | 2021-12-31 | 0000310158-22-000003 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0000310158-21-000004 | EDGAR | — |
| 2020-02-26 | 2019-12-31 | 0000310158-20-000005 | EDGAR | — |
| 2019-02-27 | 2018-12-31 | 0000310158-19-000014 | EDGAR | — |
| 2018-02-27 | 2017-12-31 | 0000310158-18-000005 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-07 | 2026-06-30 | 0000310158-26-000212 | EDGAR | — |
| 2026-05-04 | 2026-03-31 | 0001628280-26-029802 | EDGAR | — |
| 2025-11-05 | 2025-09-30 | 0000310158-25-000059 | EDGAR | 42K words |
| 2025-08-05 | 2025-06-30 | 0000310158-25-000014 | EDGAR | — |
| 2025-05-02 | 2025-03-31 | 0001628280-25-021834 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0001628280-24-045689 | EDGAR | — |
| 2024-08-05 | 2024-06-30 | 0001628280-24-034715 | EDGAR | — |
| 2024-05-03 | 2024-03-31 | 0001628280-24-020283 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0001628280-23-036717 | EDGAR | — |
| 2023-08-07 | 2023-06-30 | 0001628280-23-027770 | EDGAR | — |
| 2023-05-05 | 2023-03-31 | 0001628280-23-015990 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000310158-22-000034 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-04 | 0001104659-26-090045 | EDGAR | — |
| 2026-05-28 | 0001104659-26-067509 | EDGAR | — |
| 2026-05-22 | 0001628280-26-037738 | EDGAR | — |
| 2026-04-30 | 0001104659-26-052081 | EDGAR | — |
| 2026-02-03 | 0001104659-26-009495 | EDGAR | 9K words |
| 2025-12-04 | 0001628280-25-055388 | EDGAR | — |
| 2025-10-30 | 0001104659-25-103974 | EDGAR | — |
| 2025-09-09 | 0000310158-25-000047 | EDGAR | — |
| 2025-07-29 | 0001104659-25-071380 | EDGAR | — |
| 2025-05-29 | 0001104659-25-054131 | EDGAR | — |
135 total filings indexed. 104 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| Call Date | Quarter | Title |
|---|---|---|
| — | MRK Earnings Call Transcript | |
| — | MRK Earnings Call Transcript | |
| — | MRK Earnings Call Transcript | |
| — | MRK Earnings Call Transcript | |
| — | MRK Earnings Call Transcript | |
| — | MRK Earnings Call Transcript |
Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.
| CIK | 0000310158 |
| Ticker | MRK |
| Exchange | NYSE |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NJ |
| Website | https://www.merck.com |
| Listed | 1949-04-20 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/MRK (~200 tokens, structured JSON with cryptographic provenance)